Influenza A virus subtype H2N2

From WikiMD's WELLNESSPEDIA

Influenza A virus subtype H2N2 (H2N2) is a subtype of the Influenza A virus. Also known as Asian Flu, it originated from an avian influenza virus and was responsible for the 1957–1958 influenza pandemic.

Origin[edit]

The H2N2 subtype was first identified in 1957 in East Asia. It is believed to have evolved from a recombination of the Influenza A virus subtype H1N1 and an avian influenza virus. The H2N2 subtype has not been detected in humans since 1968, but it continues to circulate in bird populations.

Epidemiology[edit]

The H2N2 subtype caused an estimated one to two million deaths globally during the 1957–1958 pandemic, with high mortality rates among the elderly. The virus was able to spread rapidly due to the lack of immunity in the human population.

Symptoms[edit]

The symptoms of H2N2 infection are similar to those of other influenza viruses and can include fever, cough, sore throat, body aches, headache, chills, and fatigue. Severe infections can lead to pneumonia and other complications.

Prevention and Treatment[edit]

Vaccination is the most effective way to prevent infection with the H2N2 subtype. Antiviral drugs such as oseltamivir and zanamivir can be used to treat infection.

See Also[edit]



Infectious diseases – viral systemic diseases
Oncovirus
Immune disorders
Central
nervous system
Cardiovascular
Respiratory system/
acute viral
nasopharyngitis/
viral pneumonia




Pandemics
Specific pandemics
Related topics
Pandemic prevention
Pandemic response
This pandemic related article is a stub.



This Influenza-related article is a stub. You can help WikiMD by expanding the page.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Influenza_A_virus_subtype_H2N2&oldid=6304012"